| Sign In to gain access to subscriptions and/or personal tools. |
Synthesis of New Poly(N-Vinyl Pyrrolidone-Co-Maleic Acid) Peptide Hormone Conjugates with Anticancer ActivityCentral Research Institute for Chemistry, POB 17 1525, Budapest, Hungary
Central Research Institute for Chemistry, POB 17 1525, Budapest, Hungary
Semmulweis University Medical School, Puskin u. 9 1080, Budapest, Hungary
Semmulweis University Medical School, Puskin u. 9 1080, Budapest, Hungary
Semmulweis University Medical School, Puskin u. 9 1080, Budapest, Hungary
National Institute of Oncology, Ráth Gy. u. 7-9 1122, Budapest, Hungary
National Institute of Oncology, Ráth Gy. u. 7-9 1122, Budapest, Hungary
National Institute of Oncology, Ráth Gy. u. 7-9 1122, Budapest, Hungary Gonadotropin releasing hormone (GnRH) is a decapeptide regulating the gonadotropin release in organisms. Its analogues inhibit breast, endometrium and prostatic tumor cell proliferation in vitro. Some analogues were conjugated via the lysine side chain to poly(N-vinyl pyrrolidone-co-maleic acid) using biodegradable and non-biodegradable oligopeptide spacers. The conjugates were prepared by acylation of oligopeptide nitrophenyl esters with the polymeric precursor, poly(N-vinyl pyrrolidone-co-maleic anhydride), by reacting the GnRH analogues with the polymeric active ester. In vitro tests of these products exhibited increased effects on MCF-7 and MDA MB-231 breast, Ishikawa endometrium and PC3 prostatic human tumor cells compared with the parent decapeptides.
Journal of Bioactive and Compatible Polymers, Vol. 14, No. 4,
304-314 (1999) |
|||